the emerald trial | virginia kaklamani, md
Published 1 year ago • 384 plays • Length 3:32Download video MP4
Download video MP3
Similar videos
-
1:30
genomic testing emerald trial video
-
1:01
what emerald phase iii trial could mean for breast cancer patients | virginia kaklamani, md
-
0:38
top 5 facts video emerald trial video
-
17:11
emerald lead to the elacestrant fda approval - oncbrothers in discussion w/ dr. virginia kaklamani
-
1:00:42
стратешки дијалог са бранимиром несторовићем - учесталост оболевања од карцинома је порасла за 300%
-
20:37
gs2-02: "elacestrant, an oral selective estrogen receptor degrader (serd), vs investigator’s..."
-
57:46
neue ergebnisse bei der behandlung von fortgeschrittenem brustkrebs vom sabcs-kongress 2022
-
0:30
the impact of the emerald trial results based on duration of prior cdk4/6i in the metastatic setting
-
1:11
value of offering clinical trials to patients | the new cancer quest
-
1:06
the new cancer quest and what it means for you | kate lathrop, md
-
21:03
how to treat hr breast cancer with dr. virginia kaklamani | onc brothers
-
2:01
surgical treatments available for lymphedema caused by cancer
-
8:54
sabcs 2022丨interview with professor virginia g. kaklamani: celebrating a wonderful winter symposium
-
1:13
dr. kaklamani discusses bone health in women with breast cancer
-
4:06
md anderson research: breakthroughs in cancer treatment
-
0:31
clinical trials - community health network md anderson cancer center
-
0:46
update of emerald by duration of cdk4/6i in metastatic setting: elacestrant v soc in er /her2- mbc
-
4:23
mays cancer center discoveries: a newly uncovered vulnerability to help treat hard-to-treat cancers
-
1:42
impact story: md anderson cancer center
-
5:58
sabcs 2017 – virginia g kaklamani